Detection of minimal bactericidal concentration of Anerdian skin disinfectant against clinical drug-resistant bacterial strains

Xi-mao WEN,Xun HUANG,Jie LI,Xin HUANG,An-hua WU

DOI: https://doi.org/10.11726/j.issn.1001-7658.2017.08.003

2017-01-01

Abstract:Objective To determine the minimal bactericidal concentration(MBC)of iodine-containing disinfectant against clinical drug-resistant bacterial strains.Methods Anerdian was used as studied object,doubling dilution method was adopted,Anerdian of different concentrations was contacted with clinical drug-resistant bacterial strains,standard strain Escherichia coli(8099),and Staphylococcus aureus(ATCC 6538)for 1,3,and 5 min respectively,and bactericidal efficacy was observed.Results All detected bacteria were killed by Anerdian which containing 7.81 mg/L available iodine in 1min,by Anerdian which containing 3.90 mg/L available iodine in 5 min.But when contact time was 1min,MBCs of 7 strains of clinically isolated Staphylococcus aureus(7.81 mg/L) were higher than that of standard strain of Staphylococcus aureus(3.90 mg/L);when contact time was 5 min,MBCs of 18 strains of isolated Gram-negative bacteria(3.90 mg/L)were higher than standard strain of Escherichia coli (<1.95 mg/L).Conclusion Resistance of most clinical multidrug-resistant strains to Anerdian is not higher than the standard strain,and Anerdian still presents a good bactericidal efficacy.